Price $52.50 |
Market Cap
942M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
114.6
|
P/B
9.79
|
P/S
5.83
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
117.6
|
Op. Cash Flow
12.5K
|
FCF
0.4
|
|
Op. Margin
1.90%
|
Net Margin
5.30%
|
ROE
9.50%
|
ROI
6.90%
|
|
ROA
7.80%
|
EPS Growth
5.50%
|
Current Ratio
5.3
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Dyadic International, Inc. (DYAI) | $6.00 | - | - | 120.1M | Strong Buy |
| Champions Oncology Inc (CSBR) | $7.81 | - | - | 110.8M | Strong Buy |
| Cesca Therapeutics Inc (KOOL) | $2.63 | - | - | 6.1M | Strong Buy |
| Celexus Inc (CXUS) | $1.61 | - | - | 5.2M | Strong Buy |
| Lannett Company, Inc. (LCI) | $5.90 | - | - | 215.5M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
